Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hyperlipoproteinemias

  Free Subscription


Articles published in Can J Cardiol

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    March 2020
  1. LAZARTE J, Hegele RA
    Pediatric Dyslipidemia-Beyond Familial Hypercholesterolemia.
    Can J Cardiol. 2020 Mar 23. pii: S0828-282X(20)30275.
    PubMed     Abstract available


    August 2019
  2. GUPTA M
    Finding the Familial Hypercholesterolemia Needle in Acute Coronary Syndrome: The Haystack Is Smaller Than You Think.
    Can J Cardiol. 2019 Aug 5. pii: S0828-282X(19)31111.
    PubMed    


    July 2019
  3. SPARROW RT, Ferreira-Legere L, Udell JA, Waters DD, et al
    Improving Statin Noncompliance: If You Build It, Will They Come?
    Can J Cardiol. 2019;35:813-815.
    PubMed    


    June 2019
  4. KRAMER AI, Trinder M, Brunham LR
    Estimating the Prevalence of Familial Hypercholesterolemia in Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2019 Jun 24. pii: S0828-282X(19)30433.
    PubMed     Abstract available


  5. BANERJEE A, Alothman L, Couture P, Bergeron J, et al
    The Lifelong Burden of Homozygous Familial Hypercholesterolemia.
    Can J Cardiol. 2019 Jun 13. pii: S0828-282X(19)30425.
    PubMed     Abstract available


  6. BERARD E, Bongard V, Haas B, Dallongeville J, et al
    Prevalence and Treatment of Familial Hypercholesterolemia in France.
    Can J Cardiol. 2019;35:744-752.
    PubMed     Abstract available


  7. FRANCIS GA, Brunham LR
    Low Rates of Identification and Treatment of Familial Hypercholesterolemia in France and Elsewhere: A Call for Universal Screening.
    Can J Cardiol. 2019;35:699-700.
    PubMed    


    May 2019
  8. PAROLINI C, Adorni MP, Busnelli M, Manzini S, et al
    Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic Rabbits.
    Can J Cardiol. 2019 May 30. pii: S0828-282X(19)30379.
    PubMed     Abstract available


    March 2019
  9. HSUE PY
    Mechanisms of Cardiovascular Disease in the Setting of HIV Infection.
    Can J Cardiol. 2019;35:238-248.
    PubMed     Abstract available


    December 2018
  10. BRUNHAM LR, Ruel I, Aljenedil S, Riviere JB, et al
    Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018.
    Can J Cardiol. 2018;34:1553-1563.
    PubMed     Abstract available


    October 2018
  11. IACOCCA MA, Wang J, Sarkar S, Dron JS, et al
    Whole-Gene Duplication of PCSK9 as a Novel Genetic Mechanism for Severe Familial Hypercholesterolemia.
    Can J Cardiol. 2018;34:1316-1324.
    PubMed     Abstract available


  12. PAQUETTE M, Baass A
    A Novel Cause of Familial Hypercholesterolemia: PCSK9 Gene Duplication.
    Can J Cardiol. 2018;34:1259-1260.
    PubMed    


    August 2018
  13. BAASS A, Hegele RA
    Getting Real With PCSK9 Inhibitors in Familial Hypercholesterolemia.
    Can J Cardiol. 2018;34:959-961.
    PubMed    


  14. RAZEK O, Cermakova L, Armani H, Lee T, et al
    Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 Inhibitors.
    Can J Cardiol. 2018;34:1004-1009.
    PubMed     Abstract available


    July 2018
  15. MCPHERSON R
    The Cardiovascular Burden of Undiagnosed Familial Hypercholesterolemia: Need to Modify Guidelines to Encourage Earlier Diagnosis and Therapy.
    Can J Cardiol. 2018 Jul 11. pii: S0828-282X(18)30503.
    PubMed    


    May 2018
  16. RUEL I, Brisson D, Aljenedil S, Awan Z, et al
    Simplified Canadian Definition for Familial Hypercholesterolemia.
    Can J Cardiol. 2018 May 19. pii: S0828-282X(18)30383.
    PubMed     Abstract available


  17. MANCINI GBJ, Hegele RA
    Can We Eliminate Low-Density Lipoprotein Cholesterol-Related Cardiovascular Events Through More Aggressive Primary Prevention Therapy?
    Can J Cardiol. 2018;34:546-551.
    PubMed     Abstract available


    October 2017
  18. PAQUETTE M, Dufour R, Baass A
    Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
    Can J Cardiol. 2017;33:1312-1318.
    PubMed     Abstract available


    May 2017
  19. AL KINDI M, Belanger AM, Sayegh K, Senouci S, et al
    Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia.
    Can J Cardiol. 2017;33:658-665.
    PubMed     Abstract available


  20. RAJAMANNAN NM, Nattel S
    Aortic Vascular Calcification: Cholesterol Lowering Does Not Reduce Progression in Patients With Familial Hypercholesterolemia-or Does It?
    Can J Cardiol. 2017;33:594-596.
    PubMed    


  21. NAUGLER C, Cook C, Morrin L, Wesenberg J, et al
    Statin Prescriptions for High-Risk Patients Are Increased by Laboratory-Initiated Framingham Risk Scores: A Quality-Improvement Initiative.
    Can J Cardiol. 2017;33:682-684.
    PubMed     Abstract available


  22. BRENNAN ET, Joy TR
    Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
    Can J Cardiol. 2017;33:666-673.
    PubMed     Abstract available


    March 2017
  23. FILLER G, Lee M, Hegele RA
    Barriers to the Implementation of Lipoprotein Apheresis in Canada.
    Can J Cardiol. 2017;33:409-411.
    PubMed     Abstract available


  24. WATERS DD, Boekholdt SM
    An Evidence-Based Guide to Cholesterol-Lowering Guidelines.
    Can J Cardiol. 2017;33:343-349.
    PubMed     Abstract available


    November 2016
  25. GENEST J
    Familial Hypercholesterolemia: Awareness, Appraisal, and Action.
    Can J Cardiol. 2016 Nov 14. pii: S0828-282X(16)31014.
    PubMed    


    September 2016
  26. BRUNHAM LR, Cermakova L, Lee T, Priecelova I, et al
    Contemporary Trends in the Management and Outcomes of Patients With Familial Hypercholesterolemia in Canada: A Prospective Observational Study.
    Can J Cardiol. 2016 Sep 3. pii: S0828-282X(16)30892.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: